Schott Pharma AG KGaASHTPY -42.88%64 Days Inventory is 96.63 as of Mar. 2026, which is 24% above its 10-year median of 77.97. GuruFocus rates SHTPY with a GF Score™ of 64/100 and a GF Value™ of $7.02. The stock has 2 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Schott Pharma AG KGaA ranks better than 82.7% on this metric.
The historical rank and industry rank for Schott Pharma AG KGaA's Days Inventory or its related term are showing as below:
SHTPY'
s Days Inventory Range Over the Past 10 Years
Min: 59.44 Med: 77.97 Max: 94.45
Current: 94.45
During the past 6 years, Schott Pharma AG KGaA's highest Days Inventory was 94.45. The lowest was 59.44. And the median was 77.97.
SHTPY's Days Inventory is ranked better than 82.7% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs SHTPY: 94.45
Inventory Turnover measures how fast the company turns over its inventory within a year.
Schott Pharma AG KGaA's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.94.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Schott Pharma AG KGaA's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.74.
Schott Pharma AG KGaA (OTCPK:SHTPY) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Schott Pharma AG KGaA's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Schott Pharma AG KGaA's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Schott Pharma AG KGaA Days Inventory Related Terms
Schott Pharma AG KGaA Days Inventory Historical Data
* Premium members only.
The historical data trend for Schott Pharma AG KGaA's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHTPY vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Schott Pharma AG KGaA Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's Days Inventory distribution charts can be found below:
* The bar in red indicates where Schott Pharma AG KGaA's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Schott Pharma AG KGaA (SHTPY) has a Days Inventory of 96.63 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Schott Pharma AG KGaA and its competitors. This is 24% above median its historical median of 77.97. Over the past decade, Schott Pharma AG KGaA's Days Inventory has ranged from 59.44 to 94.45. According to the industry distribution chart, Schott Pharma AG KGaA ranks #136 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 17.3%.
Is Schott Pharma AG KGaA's Days Inventory too high?
Schott Pharma AG KGaA's current Days Inventory of 96.63 is 24% above median its 10-year median of 77.97. Over the past 10 years, this metric has ranged from a low of 59.44 to a high of 94.45. The Medical Devices & Instruments industry median Days Inventory is 179.60. Schott Pharma AG KGaA's value of 96.63 is 46.2% below this industry median. Based on the distribution chart, Schott Pharma AG KGaA ranks #136 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Schott Pharma AG KGaA has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Schott Pharma AG KGaA's Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Schott Pharma AG KGaA ranks #136 out of 786 companies for Days Inventory. This places Schott Pharma AG KGaA in the top 17% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.60. Schott Pharma AG KGaA's value of 96.63 is 46.2% below this benchmark. Historically, Schott Pharma AG KGaA's own Days Inventory has ranged from 59.44 to 94.45 over the past decade. While the company's 10-year median is 77.97 vs. the industry median of 179.60, Schott Pharma AG KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Schott Pharma AG KGaA's current Days Inventory of 96.63 is 46.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Schott Pharma AG KGaA and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Schott Pharma AG KGaA's current Days Inventory is 96.63, which is 24% above median its own 10-year median of 77.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Schott Pharma AG KGaA stock overvalued right now?
Schott Pharma AG KGaA (SHTPY) has a current Days Inventory of 96.63. The stock's GF Value™ is $7.02, compared to a current price of $4.37 — trading 37.7% below its estimated fair value. The current Days Inventory is 96.63, which is 24% above median its 10-year median of 77.97 and 46.2% below the Medical Devices & Instruments industry median of 179.60. Schott Pharma AG KGaA's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Schott Pharma AG KGaA (SHTPY), the current Days Inventory is 96.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Schott Pharma AG KGaA (SHTPY) Overvalued in 2026?
Based on GuruFocus' analysis, Schott Pharma AG KGaA stock appears to be undervalued.
The current stock price of $4.37 is trading 37.7% below its estimated GF Value™ of $7.02.
Key valuation signals for SHTPY:
Days Inventory: 96.63 (24% above median its 10-year median of 77.97)
GF Value™: $7.02 vs. price of $4.37 (37.7% below fair value)
Industry Position: 46.2% below the Medical Devices & Instruments median (#136 of 786)
No single metric tells the full story. See the SHTPY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Schott Pharma AG & CO KGaA is an international provider of drug containment solutions and delivery systems for injectable drugs for pharma, biotech and life-sciences. Its business operates in two segments: Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of revenue is being generated from the DCS segment, which includes products like vials, cartridges, and ampoules, and provides customers with sterile and non-sterile options in standard and high-end formats for drug storage. Geographically, the company generates revenue from Europe, the Middle East, Africa (EMEA), Asia and the South Pacific, North America, and South America.
64GF Score
Get the complete analysis for SHTPY
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHTPY has been successfully added to your 
